These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 647189)

  • 21. Effects of oxygen and misonidazole on cell transformation and cell killing in C3H 10T1/2 cells by X rays in vitro.
    Borsa J; Sargent MD; Einspenner M; Azzam EI; Raaphorst GP
    Radiat Res; 1984 Oct; 100(1):96-103. PubMed ID: 6494435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.
    Adams GE; Flockhart IR; Smithen CE; Stratford IJ; Wardman P; Watts ME
    Radiat Res; 1976 Jul; 67(1):9-20. PubMed ID: 940937
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of misonidazole on radiation-induced reduction of DNA bases in deaerated aqueous solution.
    Wada T; Ide H; Nishimoto S; Ono S; Kagiya T
    J Radiat Res; 1984 Mar; 25(1):99-110. PubMed ID: 6737357
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificity.
    Sutherland RM; Keng P; Conroy PJ; McDermott D; Bareham BJ; Passalacqua W
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):745-8. PubMed ID: 7107409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
    Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
    Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic potentiation of the radiosensitization of hypoxic bacterial cells afforded by nitroaromatic compounds.
    Anderson RF; Patel KB
    Radiat Res; 1983 Mar; 93(3):516-24. PubMed ID: 6344127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitroimidazoles as anti-tumor agents.
    Liu K; Zhu HL
    Anticancer Agents Med Chem; 2011 Sep; 11(7):687-91. PubMed ID: 21521156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical perspectives for the use of new hypoxic cell sensitizers.
    Brown JM
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1491-7. PubMed ID: 6216229
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione depletion by 2-nitroimidazole-1-acetohydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes.
    Takanuki K; Igarashi T; Hata K; Hori H; Shibata T; Kitagawa H; Satoh T; Inayama S
    Biochem Int; 1988 Jul; 17(1):155-62. PubMed ID: 3190713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of lipophilicity on the rate of diffusion of sensitizers into cellular targets.
    Kandaiya S
    Singapore Med J; 1985 Feb; 26(1):49-52. PubMed ID: 4023724
    [No Abstract]   [Full Text] [Related]  

  • 32. Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells.
    Taylor YC; Rauth AM
    Cancer Res; 1978 Sep; 38(9):2745-52. PubMed ID: 679180
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiosensitization of Chinese hamster cells by pimonidazole (Ro 03-8799) at low X-ray doses.
    Watts ME; Woodcock M
    Br J Radiol; 1991 Oct; 64(766):971-4. PubMed ID: 1954543
    [No Abstract]   [Full Text] [Related]  

  • 34. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM; Chin J; Marchow L; Paciga J
    Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.
    Adams GE; Flockhart IR; Smithen CE; Stratford IJ; Wardman P; Watts ME
    Radiat Res; 2012 Aug; 178(2):AV183-9. PubMed ID: 22870968
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers.
    Stratford IJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):391-8. PubMed ID: 7050037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
    Rofstad EK; Brustad T
    Br J Radiol; 1978 May; 51(605):381-6. PubMed ID: 638410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study on the radiosensitizing effects and cytotoxic properties of misonidazole and 2,4-dinitroimidazole-1-ethanol in HeLa S3 cells.
    Murayama C; Hori H; Inayama S; Mori T
    Gan; 1982 Aug; 73(4):588-91. PubMed ID: 7152197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azomycin riboside, a sugar homologue of misonidazole with favorable radiosensitizing properties.
    Jarvis SM; Chapman JD; Ngan-Lee J; Rutledge KA; Barr PJ; Paterson AR
    Cancer Res; 1982 Nov; 42(11):4358-63. PubMed ID: 7127280
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiosensitizing drugs in relation to individualized treatment.
    Adams GE
    Strahlentherapie; 1984 Nov; 160(11):688-94. PubMed ID: 6506108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.